ArticleGenes, chromosomes & cancer2022

FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumor.

Josephine K Dermawan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.